Genome technology integration service platform




2025.01.15 Signed an agency contract with Manila HealthTek in the Philippines

Year of Establishment

Number of Samples Handled

Species Types Handled

Domestic and International Clients


Technical

Technical


Sanger Sequencing

Amplicon sequencing is a high-throughput DNA sequencing technique specifically used to analyze target gene regions. It typically utilizes customized PCR to select and amplify the desired sequences, followed by Next-Generation Sequencing (NGS) for sequencing. This method is widely applied in various fields, such as microbial diversity studies, genetic variation detection, and cancer gene research.

Plasmid sequencing is a genetic sequencing technique specifically used to analyze the complete DNA sequence of plasmids to ensure their accuracy, detect mutations, or identify functional elements such as promoters, antibiotic resistance genes, and reporter genes. This technique is crucial in molecular biology, synthetic biology, genetic engineering, and medical research.

Short-Read Sequencing ( Illumina )

Amplicon sequencing is a high-throughput DNA sequencing technique specifically used to analyze target gene regions. It typically utilizes customized PCR to select and amplify the desired sequences, followed by Next-Generation Sequencing (NGS) for sequencing. This method is widely applied in various fields, such as microbial diversity studies, genetic variation detection, and cancer gene research.

Plasmid sequencing is a genetic sequencing technique specifically used to analyze the complete DNA sequence of plasmids to ensure their accuracy, detect mutations, or identify functional elements such as promoters, antibiotic resistance genes, and reporter genes. This technique is crucial in molecular biology, synthetic biology, genetic engineering, and medical research.

mRNA-seq (messenger RNA sequencing) is a high-throughput sequencing technology designed to analyze the transcriptome, which represents gene expression in cells or tissues. This technique is primarily based on Illumina short-read sequencing platforms, providing accurate and large-scale RNA sequence information. It is widely used in biomedical research, gene expression studies, and disease mechanism investigations.

Human Whole Exome Sequencing (WES) is a high-throughput sequencing technology that focuses on sequencing the exonic regions of the genome, which contain protein-coding genes. Since exons only make up about 1–2% of the human genome but harbor approximately 85% of known disease-related variants, WES provides a cost-effective and efficient method for detecting genetic variations associated with diseases, hereditary conditions, and functional mutations.

Human Whole Genome Sequencing (WGS) is a high-throughput sequencing technology that deciphers the entire 3 billion base pairs of the human genome. Unlike Whole Exome Sequencing (WES), which focuses only on coding regions (exons), WGS covers both coding and non-coding regions, including regulatory elements, intergenic regions, and structural variations. This makes WGS the most comprehensive method for identifying genetic variations, structural rearrangements, and disease-associated mutations.

Shotgun metagenomic sequencing is a high-throughput sequencing approach used to analyze the entire genetic content of microbial communities in an unbiased, culture-independent manner. Unlike 16S rRNA sequencing, which focuses only on bacterial taxonomy, shotgun metagenomics enables the comprehensive study of microbial diversity, functional genes, metabolic pathways, and microbial interactions within an ecosystem. This method is widely applied in environmental microbiology, human microbiome research, infectious disease studies, and biotechnology applications.

RAD-seq (Restriction-site Associated DNA Sequencing) is a cost-effective reduced-representation sequencing technique used to study genetic variation across the genome. By targeting regions flanking restriction enzyme cut sites, RAD-seq enables high-resolution SNP (Single Nucleotide Polymorphism) discovery, making it particularly useful for population genetics, evolutionary biology, phylogenetics, and marker-assisted selection. Unlike whole-genome sequencing (WGS), which sequences the entire genome, RAD-seq focuses only on specific genomic regions, significantly reducing sequencing costs while maintaining high informativeness.

Long-Read Sequencing ( Nanopore / PacBio )


Nanopore

Human Whole Genome Sequencing (WGS) using the Nanopore long-read platform provides a comprehensive and real-time approach to sequencing the entire human genome. Unlike short-read technologies (e.g., Illumina), Nanopore sequencing (Oxford Nanopore Technologies, ONT) enables the generation of ultra-long reads (up to several megabases) that improve genome assembly, structural variant detection, and epigenetic analysis. This technology is particularly valuable for complex genomic regions, repetitive sequences, and phased genome assembly.

Plasmid sequencing using the Nanopore long-read platform provides a real-time, high-throughput approach for fully reconstructing plasmid genomes. Unlike short-read sequencing, which may result in fragmented assemblies, Nanopore sequencing (Oxford Nanopore Technologies, ONT) enables full-length plasmid sequencing in single reads, resolving complex repeat regions, structural variations, and mobile genetic elements. This technology is particularly useful for antibiotic resistance gene detection, virulence factor analysis, synthetic biology, and horizontal gene transfer studies.

Microbial Whole Genome Sequencing (WGS) using the Nanopore long-read platform provides a comprehensive method for sequencing bacterial, archaeal, fungal, and viral genomes with high accuracy and completeness. Unlike short-read sequencing (e.g., Illumina), which may struggle with repeat regions, structural variations, and plasmid assembly, Nanopore sequencing (Oxford Nanopore Technologies, ONT) generates ultra-long reads, allowing for complete genome reconstruction, including chromosomal DNA, plasmids, mobile genetic elements, and epigenetic modifications.
This approach is ideal for antibiotic resistance studies, pathogen identification, comparative genomics, evolutionary biology, and synthetic biology.

Amplicon sequencing using the Nanopore long-read platform provides a high-resolution approach for sequencing targeted genetic regions, such as 16S/18S/ITS rRNA genes, specific loci, and functional genes. Unlike short-read sequencing (e.g., Illumina), which generates fragmented reads, Nanopore sequencing (Oxford Nanopore Technologies, ONT) produces full-length amplicons in a single read, allowing for more accurate taxonomic classification, haplotype resolution, and variant detection.
This technology is widely applied in microbial community profiling, infectious disease diagnostics, phylogenetics, and functional genomics.

Metagenomic sequencing using the Nanopore long-read platform provides an unbiased, high-resolution approach to studying microbial communities by sequencing all genetic material present in a sample. Unlike targeted sequencing methods (e.g., 16S rRNA sequencing), shotgun metagenomics captures the entire genomic content of bacteria, archaea, fungi, viruses, and other microorganisms, enabling taxonomic profiling, functional gene analysis, and microbial interaction studies.
Compared to short-read sequencing (e.g., Illumina), Nanopore sequencing (Oxford Nanopore Technologies, ONT) offers ultra-long reads, which improve genome assembly, resolve repeat regions, and enhance strain-level identification in complex microbial communities.

PacBio

Amplicon sequencing using the PacBio long-read platform provides a high-resolution method for analyzing targeted genetic regions, such as 16S/18S/ITS rRNA genes, functional genes, and highly polymorphic loci. Unlike short-read sequencing (e.g., Illumina), which produces fragmented amplicons, PacBio’s Single Molecule, Real-Time (SMRT) sequencing enables full-length, high-fidelity (HiFi) amplicon sequencing, ensuring greater accuracy, haplotype resolution, and improved taxonomic classification.
This technology is widely used in microbial diversity studies, evolutionary biology, infectious disease research, and functional genomics.

Clinical Testing Services/Reagents

Precision medicine-related genetic testing focuses on identifying genetic variations that influence an individual’s drug response, disease susceptibility, and treatment outcomes. By analyzing specific genetic markers, this approach enables personalized treatment strategies, improving efficacy while reducing adverse drug reactions.
Pharmacogenetic analysis, a key component of precision medicine, utilizes quantitative PCR (qPCR) kits and other molecular techniques to assess genetic polymorphisms affecting drug metabolism, efficacy, and toxicity. These tests are essential for guiding targeted therapy decisions in oncology, cardiology, neurology, and other medical fields.

Tumor genomic testing plays a crucial role in precision oncology by identifying genetic mutations, copy number variations (CNVs), microsatellite instability (MSI), tumor mutation burden (TMB), and gene fusions associated with cancer. TruSight Oncology 500 (TSO500) is a comprehensive next-generation sequencing (NGS)-based assay designed to analyze solid tumor samples, providing highly detailed molecular profiling to guide targeted therapy decisions.
TSO500 enables the simultaneous detection of key oncogenic drivers and clinically relevant biomarkers, supporting personalized treatment strategies for various cancer types, including lung, breast, colorectal, and hematological malignancies.

Hereditary disease testing involves the identification of genetic mutations that contribute to inherited disorders. By leveraging Whole Genome Sequencing (WGS) or Whole Exome Sequencing (WES), this approach enables comprehensive screening for single nucleotide variants (SNVs), insertions/deletions (InDels), copy number variations (CNVs), and structural variants (SVs) associated with hereditary conditions.
Through advanced bioinformatics analysis, hereditary disease testing can pinpoint gene defects linked to monogenic disorders, carrier status determination, and familial risk assessments, aiding in early diagnosis, precision medicine, and genetic counseling.

Others

Oligo synthesis is a chemical process for creating short, custom-designed DNA or RNA sequences known as oligonucleotides. Using phosphoramidite chemistry, each nucleotide is added step by step, allowing precise control over sequence composition and length. After synthesis, oligos are cleaved, deprotected, and undergo purification to ensure high purity and fidelity.
Oligonucleotides play an essential role in molecular biology and biotechnology, including PCR, qPCR, gene editing (CRISPR), diagnostics, and therapeutic applications. They can be modified or labeled (e.g., with fluorescent tags or backbone modifications) to suit a wide range of specialized research and clinical needs.

Whole gene synthesis refers to the de novo chemical construction of an entire gene sequence without the need for a template DNA source. By assembling multiple short, synthetically produced oligonucleotides (oligos), researchers can create full-length genes with precise control over nucleotide composition. This technique enables tailored gene designs, such as codon optimization for specific host organisms, inclusion or exclusion of particular regulatory elements, and incorporation of desired mutations or tags.


Sanger Sequencing

Amplicon sequencing is a high-throughput DNA sequencing technique specifically used to analyze target gene regions. It typically utilizes customized PCR to select and amplify the desired sequences, followed by Next-Generation Sequencing (NGS) for sequencing. This method is widely applied in various fields, such as microbial diversity studies, genetic variation detection, and cancer gene research.

Plasmid sequencing is a genetic sequencing technique specifically used to analyze the complete DNA sequence of plasmids to ensure their accuracy, detect mutations, or identify functional elements such as promoters, antibiotic resistance genes, and reporter genes. This technique is crucial in molecular biology, synthetic biology, genetic engineering, and medical research.

Short-Read Sequencing ( Illumina )

Amplicon sequencing is a high-throughput DNA sequencing technique specifically used to analyze target gene regions. It typically utilizes customized PCR to select and amplify the desired sequences, followed by Next-Generation Sequencing (NGS) for sequencing. This method is widely applied in various fields, such as microbial diversity studies, genetic variation detection, and cancer gene research.

Plasmid sequencing is a genetic sequencing technique specifically used to analyze the complete DNA sequence of plasmids to ensure their accuracy, detect mutations, or identify functional elements such as promoters, antibiotic resistance genes, and reporter genes. This technique is crucial in molecular biology, synthetic biology, genetic engineering, and medical research.

mRNA-seq (messenger RNA sequencing) is a high-throughput sequencing technology designed to analyze the transcriptome, which represents gene expression in cells or tissues. This technique is primarily based on Illumina short-read sequencing platforms, providing accurate and large-scale RNA sequence information. It is widely used in biomedical research, gene expression studies, and disease mechanism investigations.

Human Whole Exome Sequencing (WES) is a high-throughput sequencing technology that focuses on sequencing the exonic regions of the genome, which contain protein-coding genes. Since exons only make up about 1–2% of the human genome but harbor approximately 85% of known disease-related variants, WES provides a cost-effective and efficient method for detecting genetic variations associated with diseases, hereditary conditions, and functional mutations.

Human Whole Genome Sequencing (WGS) is a high-throughput sequencing technology that deciphers the entire 3 billion base pairs of the human genome. Unlike Whole Exome Sequencing (WES), which focuses only on coding regions (exons), WGS covers both coding and non-coding regions, including regulatory elements, intergenic regions, and structural variations. This makes WGS the most comprehensive method for identifying genetic variations, structural rearrangements, and disease-associated mutations.

Shotgun metagenomic sequencing is a high-throughput sequencing approach used to analyze the entire genetic content of microbial communities in an unbiased, culture-independent manner. Unlike 16S rRNA sequencing, which focuses only on bacterial taxonomy, shotgun metagenomics enables the comprehensive study of microbial diversity, functional genes, metabolic pathways, and microbial interactions within an ecosystem. This method is widely applied in environmental microbiology, human microbiome research, infectious disease studies, and biotechnology applications.

RAD-seq (Restriction-site Associated DNA Sequencing) is a cost-effective reduced-representation sequencing technique used to study genetic variation across the genome. By targeting regions flanking restriction enzyme cut sites, RAD-seq enables high-resolution SNP (Single Nucleotide Polymorphism) discovery, making it particularly useful for population genetics, evolutionary biology, phylogenetics, and marker-assisted selection. Unlike whole-genome sequencing (WGS), which sequences the entire genome, RAD-seq focuses only on specific genomic regions, significantly reducing sequencing costs while maintaining high informativeness.

Long-Read Sequencing ( Nanopore / PacBio )


Nanopore

Human Whole Genome Sequencing (WGS) using the Nanopore long-read platform provides a comprehensive and real-time approach to sequencing the entire human genome. Unlike short-read technologies (e.g., Illumina), Nanopore sequencing (Oxford Nanopore Technologies, ONT) enables the generation of ultra-long reads (up to several megabases) that improve genome assembly, structural variant detection, and epigenetic analysis. This technology is particularly valuable for complex genomic regions, repetitive sequences, and phased genome assembly.

Plasmid sequencing using the Nanopore long-read platform provides a real-time, high-throughput approach for fully reconstructing plasmid genomes. Unlike short-read sequencing, which may result in fragmented assemblies, Nanopore sequencing (Oxford Nanopore Technologies, ONT) enables full-length plasmid sequencing in single reads, resolving complex repeat regions, structural variations, and mobile genetic elements. This technology is particularly useful for antibiotic resistance gene detection, virulence factor analysis, synthetic biology, and horizontal gene transfer studies.

Microbial Whole Genome Sequencing (WGS) using the Nanopore long-read platform provides a comprehensive method for sequencing bacterial, archaeal, fungal, and viral genomes with high accuracy and completeness. Unlike short-read sequencing (e.g., Illumina), which may struggle with repeat regions, structural variations, and plasmid assembly, Nanopore sequencing (Oxford Nanopore Technologies, ONT) generates ultra-long reads, allowing for complete genome reconstruction, including chromosomal DNA, plasmids, mobile genetic elements, and epigenetic modifications.
This approach is ideal for antibiotic resistance studies, pathogen identification, comparative genomics, evolutionary biology, and synthetic biology.

Amplicon sequencing using the Nanopore long-read platform provides a high-resolution approach for sequencing targeted genetic regions, such as 16S/18S/ITS rRNA genes, specific loci, and functional genes. Unlike short-read sequencing (e.g., Illumina), which generates fragmented reads, Nanopore sequencing (Oxford Nanopore Technologies, ONT) produces full-length amplicons in a single read, allowing for more accurate taxonomic classification, haplotype resolution, and variant detection.
This technology is widely applied in microbial community profiling, infectious disease diagnostics, phylogenetics, and functional genomics.

Metagenomic sequencing using the Nanopore long-read platform provides an unbiased, high-resolution approach to studying microbial communities by sequencing all genetic material present in a sample. Unlike targeted sequencing methods (e.g., 16S rRNA sequencing), shotgun metagenomics captures the entire genomic content of bacteria, archaea, fungi, viruses, and other microorganisms, enabling taxonomic profiling, functional gene analysis, and microbial interaction studies.
Compared to short-read sequencing (e.g., Illumina), Nanopore sequencing (Oxford Nanopore Technologies, ONT) offers ultra-long reads, which improve genome assembly, resolve repeat regions, and enhance strain-level identification in complex microbial communities.

PacBio

Amplicon sequencing using the PacBio long-read platform provides a high-resolution method for analyzing targeted genetic regions, such as 16S/18S/ITS rRNA genes, functional genes, and highly polymorphic loci. Unlike short-read sequencing (e.g., Illumina), which produces fragmented amplicons, PacBio’s Single Molecule, Real-Time (SMRT) sequencing enables full-length, high-fidelity (HiFi) amplicon sequencing, ensuring greater accuracy, haplotype resolution, and improved taxonomic classification.
This technology is widely used in microbial diversity studies, evolutionary biology, infectious disease research, and functional genomics.

Clinical Testing Services/Reagents

Precision medicine-related genetic testing focuses on identifying genetic variations that influence an individual’s drug response, disease susceptibility, and treatment outcomes. By analyzing specific genetic markers, this approach enables personalized treatment strategies, improving efficacy while reducing adverse drug reactions.
Pharmacogenetic analysis, a key component of precision medicine, utilizes quantitative PCR (qPCR) kits and other molecular techniques to assess genetic polymorphisms affecting drug metabolism, efficacy, and toxicity. These tests are essential for guiding targeted therapy decisions in oncology, cardiology, neurology, and other medical fields.

Tumor genomic testing plays a crucial role in precision oncology by identifying genetic mutations, copy number variations (CNVs), microsatellite instability (MSI), tumor mutation burden (TMB), and gene fusions associated with cancer. TruSight Oncology 500 (TSO500) is a comprehensive next-generation sequencing (NGS)-based assay designed to analyze solid tumor samples, providing highly detailed molecular profiling to guide targeted therapy decisions.
TSO500 enables the simultaneous detection of key oncogenic drivers and clinically relevant biomarkers, supporting personalized treatment strategies for various cancer types, including lung, breast, colorectal, and hematological malignancies.

Hereditary disease testing involves the identification of genetic mutations that contribute to inherited disorders. By leveraging Whole Genome Sequencing (WGS) or Whole Exome Sequencing (WES), this approach enables comprehensive screening for single nucleotide variants (SNVs), insertions/deletions (InDels), copy number variations (CNVs), and structural variants (SVs) associated with hereditary conditions.
Through advanced bioinformatics analysis, hereditary disease testing can pinpoint gene defects linked to monogenic disorders, carrier status determination, and familial risk assessments, aiding in early diagnosis, precision medicine, and genetic counseling.

Sanger Sequencing

Amplicon sequencing is a high-throughput DNA sequencing technique specifically used to analyze target gene regions. It typically utilizes customized PCR to select and amplify the desired sequences, followed by Next-Generation Sequencing (NGS) for sequencing. This method is widely applied in various fields, such as microbial diversity studies, genetic variation detection, and cancer gene research.

Plasmid sequencing is a genetic sequencing technique specifically used to analyze the complete DNA sequence of plasmids to ensure their accuracy, detect mutations, or identify functional elements such as promoters, antibiotic resistance genes, and reporter genes. This technique is crucial in molecular biology, synthetic biology, genetic engineering, and medical research.

Short-Read Sequencing ( Illumina )

Amplicon sequencing is a high-throughput DNA sequencing technique specifically used to analyze target gene regions. It typically utilizes customized PCR to select and amplify the desired sequences, followed by Next-Generation Sequencing (NGS) for sequencing. This method is widely applied in various fields, such as microbial diversity studies, genetic variation detection, and cancer gene research.

Plasmid sequencing is a genetic sequencing technique specifically used to analyze the complete DNA sequence of plasmids to ensure their accuracy, detect mutations, or identify functional elements such as promoters, antibiotic resistance genes, and reporter genes. This technique is crucial in molecular biology, synthetic biology, genetic engineering, and medical research.

Human Whole Genome Sequencing (WGS) is a high-throughput sequencing technology that deciphers the entire 3 billion base pairs of the human genome. Unlike Whole Exome Sequencing (WES), which focuses only on coding regions (exons), WGS covers both coding and non-coding regions, including regulatory elements, intergenic regions, and structural variations. This makes WGS the most comprehensive method for identifying genetic variations, structural rearrangements, and disease-associated mutations.

Shotgun metagenomic sequencing is a high-throughput sequencing approach used to analyze the entire genetic content of microbial communities in an unbiased, culture-independent manner. Unlike 16S rRNA sequencing, which focuses only on bacterial taxonomy, shotgun metagenomics enables the comprehensive study of microbial diversity, functional genes, metabolic pathways, and microbial interactions within an ecosystem. This method is widely applied in environmental microbiology, human microbiome research, infectious disease studies, and biotechnology applications.

RAD-seq (Restriction-site Associated DNA Sequencing) is a cost-effective reduced-representation sequencing technique used to study genetic variation across the genome. By targeting regions flanking restriction enzyme cut sites, RAD-seq enables high-resolution SNP (Single Nucleotide Polymorphism) discovery, making it particularly useful for population genetics, evolutionary biology, phylogenetics, and marker-assisted selection. Unlike whole-genome sequencing (WGS), which sequences the entire genome, RAD-seq focuses only on specific genomic regions, significantly reducing sequencing costs while maintaining high informativeness.

Long-Read Sequencing ( Nanopore / PacBio )


Nanopore

Human Whole Genome Sequencing (WGS) using the Nanopore long-read platform provides a comprehensive and real-time approach to sequencing the entire human genome. Unlike short-read technologies (e.g., Illumina), Nanopore sequencing (Oxford Nanopore Technologies, ONT) enables the generation of ultra-long reads (up to several megabases) that improve genome assembly, structural variant detection, and epigenetic analysis. This technology is particularly valuable for complex genomic regions, repetitive sequences, and phased genome assembly.

Plasmid sequencing using the Nanopore long-read platform provides a real-time, high-throughput approach for fully reconstructing plasmid genomes. Unlike short-read sequencing, which may result in fragmented assemblies, Nanopore sequencing (Oxford Nanopore Technologies, ONT) enables full-length plasmid sequencing in single reads, resolving complex repeat regions, structural variations, and mobile genetic elements. This technology is particularly useful for antibiotic resistance gene detection, virulence factor analysis, synthetic biology, and horizontal gene transfer studies.

Microbial Whole Genome Sequencing (WGS) using the Nanopore long-read platform provides a comprehensive method for sequencing bacterial, archaeal, fungal, and viral genomes with high accuracy and completeness. Unlike short-read sequencing (e.g., Illumina), which may struggle with repeat regions, structural variations, and plasmid assembly, Nanopore sequencing (Oxford Nanopore Technologies, ONT) generates ultra-long reads, allowing for complete genome reconstruction, including chromosomal DNA, plasmids, mobile genetic elements, and epigenetic modifications.
This approach is ideal for antibiotic resistance studies, pathogen identification, comparative genomics, evolutionary biology, and synthetic biology.

Amplicon sequencing using the Nanopore long-read platform provides a high-resolution approach for sequencing targeted genetic regions, such as 16S/18S/ITS rRNA genes, specific loci, and functional genes. Unlike short-read sequencing (e.g., Illumina), which generates fragmented reads, Nanopore sequencing (Oxford Nanopore Technologies, ONT) produces full-length amplicons in a single read, allowing for more accurate taxonomic classification, haplotype resolution, and variant detection.
This technology is widely applied in microbial community profiling, infectious disease diagnostics, phylogenetics, and functional genomics.

Metagenomic sequencing using the Nanopore long-read platform provides an unbiased, high-resolution approach to studying microbial communities by sequencing all genetic material present in a sample. Unlike targeted sequencing methods (e.g., 16S rRNA sequencing), shotgun metagenomics captures the entire genomic content of bacteria, archaea, fungi, viruses, and other microorganisms, enabling taxonomic profiling, functional gene analysis, and microbial interaction studies.
Compared to short-read sequencing (e.g., Illumina), Nanopore sequencing (Oxford Nanopore Technologies, ONT) offers ultra-long reads, which improve genome assembly, resolve repeat regions, and enhance strain-level identification in complex microbial communities.

PacBio

Amplicon sequencing using the PacBio long-read platform provides a high-resolution method for analyzing targeted genetic regions, such as 16S/18S/ITS rRNA genes, functional genes, and highly polymorphic loci. Unlike short-read sequencing (e.g., Illumina), which produces fragmented amplicons, PacBio’s Single Molecule, Real-Time (SMRT) sequencing enables full-length, high-fidelity (HiFi) amplicon sequencing, ensuring greater accuracy, haplotype resolution, and improved taxonomic classification.
This technology is widely used in microbial diversity studies, evolutionary biology, infectious disease research, and functional genomics.

Clinical Testing Services/Reagents

Precision medicine-related genetic testing focuses on identifying genetic variations that influence an individual’s drug response, disease susceptibility, and treatment outcomes. By analyzing specific genetic markers, this approach enables personalized treatment strategies, improving efficacy while reducing adverse drug reactions.
Pharmacogenetic analysis, a key component of precision medicine, utilizes quantitative PCR (qPCR) kits and other molecular techniques to assess genetic polymorphisms affecting drug metabolism, efficacy, and toxicity. These tests are essential for guiding targeted therapy decisions in oncology, cardiology, neurology, and other medical fields.

Tumor genomic testing plays a crucial role in precision oncology by identifying genetic mutations, copy number variations (CNVs), microsatellite instability (MSI), tumor mutation burden (TMB), and gene fusions associated with cancer. TruSight Oncology 500 (TSO500) is a comprehensive next-generation sequencing (NGS)-based assay designed to analyze solid tumor samples, providing highly detailed molecular profiling to guide targeted therapy decisions.
TSO500 enables the simultaneous detection of key oncogenic drivers and clinically relevant biomarkers, supporting personalized treatment strategies for various cancer types, including lung, breast, colorectal, and hematological malignancies.

Hereditary disease testing involves the identification of genetic mutations that contribute to inherited disorders. By leveraging Whole Genome Sequencing (WGS) or Whole Exome Sequencing (WES), this approach enables comprehensive screening for single nucleotide variants (SNVs), insertions/deletions (InDels), copy number variations (CNVs), and structural variants (SVs) associated with hereditary conditions.
Through advanced bioinformatics analysis, hereditary disease testing can pinpoint gene defects linked to monogenic disorders, carrier status determination, and familial risk assessments, aiding in early diagnosis, precision medicine, and genetic counseling.

Others

Oligo synthesis is a chemical process for creating short, custom-designed DNA or RNA sequences known as oligonucleotides. Using phosphoramidite chemistry, each nucleotide is added step by step, allowing precise control over sequence composition and length. After synthesis, oligos are cleaved, deprotected, and undergo purification to ensure high purity and fidelity.
Oligonucleotides play an essential role in molecular biology and biotechnology, including PCR, qPCR, gene editing (CRISPR), diagnostics, and therapeutic applications. They can be modified or labeled (e.g., with fluorescent tags or backbone modifications) to suit a wide range of specialized research and clinical needs.

Whole gene synthesis refers to the de novo chemical construction of an entire gene sequence without the need for a template DNA source. By assembling multiple short, synthetically produced oligonucleotides (oligos), researchers can create full-length genes with precise control over nucleotide composition. This technique enables tailored gene designs, such as codon optimization for specific host organisms, inclusion or exclusion of particular regulatory elements, and incorporation of desired mutations or tags.

Short-Read Sequencing ( Illumina )

mRNA-seq (messenger RNA sequencing) is a high-throughput sequencing technology designed to analyze the transcriptome, which represents gene expression in cells or tissues. This technique is primarily based on Illumina short-read sequencing platforms, providing accurate and large-scale RNA sequence information. It is widely used in biomedical research, gene expression studies, and disease mechanism investigations.

Human Whole Exome Sequencing (WES) is a high-throughput sequencing technology that focuses on sequencing the exonic regions of the genome, which contain protein-coding genes. Since exons only make up about 1–2% of the human genome but harbor approximately 85% of known disease-related variants, WES provides a cost-effective and efficient method for detecting genetic variations associated with diseases, hereditary conditions, and functional mutations.

Others

Oligo synthesis is a chemical process for creating short, custom-designed DNA or RNA sequences known as oligonucleotides. Using phosphoramidite chemistry, each nucleotide is added step by step, allowing precise control over sequence composition and length. After synthesis, oligos are cleaved, deprotected, and undergo purification to ensure high purity and fidelity.
Oligonucleotides play an essential role in molecular biology and biotechnology, including PCR, qPCR, gene editing (CRISPR), diagnostics, and therapeutic applications. They can be modified or labeled (e.g., with fluorescent tags or backbone modifications) to suit a wide range of specialized research and clinical needs.

Whole gene synthesis refers to the de novo chemical construction of an entire gene sequence without the need for a template DNA source. By assembling multiple short, synthetically produced oligonucleotides (oligos), researchers can create full-length genes with precise control over nucleotide composition. This technique enables tailored gene designs, such as codon optimization for specific host organisms, inclusion or exclusion of particular regulatory elements, and incorporation of desired mutations or tags.
About Adaptor

About Adaptor

Named "Adaptor" after the role of the Adaptor in sequencing, we aspire to play a role in bridging and transforming in the fields of biology and information technology. We aim to become the best partner for academia and industry in sample preparation and data analysis, overcoming challenges in this rapidly changing era with the role of an adaptor and creating endless possibilities together.

Development Goals

Adaptor is dedicated to building a "customer-oriented genomic technology integration service platform," providing a series of services from front-end sample preparation and library construction to back-end data processing and analysis. Our aim is to enable the widespread application of new genomic technologies in Taiwan. Currently, through collaboration with Kaohsiung Medical University, we are enhancing the linkage between genomic science and industry applications. This strengthens the integration and completeness of each part of our service platform, allowing us to tailor custom analysis processes to meet both academic and industrial needs. By adopting a "understanding needs, providing solutions" approach, we strive to precisely overcome the challenges in the current bioscience market.
Customized Consultation Services

Customized Consultation Services

We offer genomic technology consultations based on the techniques you wish to apply. This helps you understand the services and analysis results you are about to receive, aligning your project, goals with the services provided by our company, and customizing the genomic services you receive.

Technical Application Consultation

Based on the RAD-seq and RNA genomic technology services provided by our company, we offer pre-experiment consultation and discussion.

Bioinformatics Consultation

Based on the bioinformatics data you obtain, we provide pre-analysis consultation to ensure that the genomic services you use meet your needs.

Customized Data Analysis

We also provide customized analysis for DNA and RNA, which can be tailored according to the references you provide. Analyses include phylogenetic tree construction, genetic structure analysis, and more.

Adaptor Team Introduction

Adaptor Team Introduction

Yi-Fan Chiu

CEO
Director of Bioinformatics

Han-Yun Li

COO
Director of R&D

Yu-Cen Wan

R&D Engineer
Bioinformatics Department

Yi-Yan Li

Data Analyst
Bioinformatics Department
Contact

Contact

Address

80708 Kaohsiung City, Sanmin District, Shiquan Road, No. 100, 12th Floor, Room N1211

Call Us

07-9769339

Email Us

Bioinformatics Department yfchiu@adaptor-genosci.com
Operations Management Department hyli@adaptor-genosci.com

Please enter your name.
Please enter a valid email.
Please enter the unit name or host.
Please enter a message.